Sg3 Management, LLC Gossamer Bio, Inc. Put Options Transaction History

Sg3 Management, LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2023 May 15, 2023	SELL	$0.96 - $2.92 $9,600 - $29,200	-10,000 Closed	0 $0
Q3 2022 May 15, 2023	BUY	$7.21 - $14.88 $72,100 - $148,800	10,000 New	10,000 $119,000
Q3 2022 Nov 14, 2022	SELL	$7.21 - $14.88 $72,100 - $148,800	-10,000 Reduced 50.0%	10,000 $120,000
Q2 2022 Aug 15, 2022	BUY	$5.97 - $9.97 $119,400 - $199,400	20,000 New	20,000 $167,000

108

167M

430K

519K

Ticker GOSS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 93,954,000
Market Cap $65.8M
Description
Gossamer Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and commercializing therapeutics in the disease areas of immunology, inflammation, and oncology in the United States. The company is developing GB002, an inhaled, small molecule, platelet-derived growth factor receptor, or PDGFR, colony...

Get notified when there are updates to the investment portfolio of Sg3 Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Sg3 Management, LLC with notifications on news.